ZimVie Inc. (ZIMV)
NASDAQ: ZIMV · Real-Time Price · USD
10.82
-0.10 (-0.87%)
Mar 31, 2025, 3:37 PM EDT - Market open

Company Description

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.

It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service.

The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors.

ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.

ZimVie Inc.
ZimVie logo
Country United States
Founded 2021
Industry Medical Devices
Sector Healthcare
Employees 1,770
CEO Vafa Jamali

Contact Details

Address:
4555 Riverside Drive
Palm Beach Gardens, Florida 33410
United States
Phone 800 342 5454
Website zimvie.com

Stock Details

Ticker Symbol ZIMV
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001876588
CUSIP Number 98888T107
ISIN Number US98888T1079
SIC Code 3843

Key Executives

Name Position
Vafa Jamali President, Chief Executive Officer and Director
Richard J. Heppenstall Executive Vice President, Chief Financial Officer and Treasurer
Heather Kidwell Senior Vice President, Chief Legal, Human Resources and Compliance Officer and Corporate Secretary
Indraneel Kanaglekar Senior Vice President and Chief Commercial Officer
Sandra Schneider Chief Accounting Officer
Steve Rondeau Senior Vice President and Chief Information Officer

Latest SEC Filings

Date Type Title
Mar 25, 2025 ARS Filing
Mar 25, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 25, 2025 DEF 14A Other definitive proxy statements
Mar 13, 2025 8-K Current Report
Feb 26, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G Filing
Feb 14, 2025 SCHEDULE 13G/A Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals